No Cover Image

Journal article 424 views

Risk of Congenital Ocular Anomaly After Prenatal Exposure to Medications: A EUROmediCAT Study

E.‐A. Cifuentes, A. Beau, A. Caillet, F. Frémont, A. J. Neville, E. Ballardini, H. Dolk Orcid Logo, M. Loane Orcid Logo, E. Garne, B. Khoshnood, N. Lelong, A. Rissmann Orcid Logo, M. O'Mahony, A. Pierini, M. Gatt, J. E. H. Bergman Orcid Logo, M. R. Krawczynski, A. Latos Bielenska, L.‐J. Echevarría González de Garibay, C. Cavero Carbonell, M.‐C. Addor, D. Tucker, Sue Jordan, E. Den Hond, V. Nelen, I. Barisic, F. Rouget, H. Randrianaivo, J. Hoareau, I. Perthus, M. Courtade‐Saïdi, C. Damase‐Michel, C. Dubucs Orcid Logo

Birth Defects Research, Volume: 117, Issue: 2, Start page: e2435

Swansea University Author: Sue Jordan

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1002/bdr2.2435

Published in: Birth Defects Research
ISSN: 2472-1727 2472-1727
Published: Wiley 2025
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa68873
Keywords: congenital ocular anomaly; in utero exposure; medications; pharmacology; pregnancy
College: Faculty of Medicine, Health and Life Sciences
Issue: 2
Start Page: e2435